BridgeBio Oncology Therapeutics Inc Annual Shareholders Meeting Transcript
Hello and welcome to the 2026 Virtual Annual Meeting of BridgeBio Oncology Therapeutics, Inc. Please note that today's meeting is being recorded. Stockholders may submit questions by following the instructions on the annual meeting interface.
Good morning, everyone. My name is Pedro J. Beltran, President and Chief Executive Officer of BridgeBio Oncology Therapeutics (technical difficulty) to record the minutes. It is a pleasure to welcome our shareholders to the annual meeting of the corporation. This meeting is being held in accordance with the corporation's bylaws and Delaware law. We will take care of the formal business at hand, which is described in our notice and proxy statement, a copy of which was mailed on or about April 28, 2026, to all of our stockholders of record at the close of business on April 20, 2026. All discussion will be limited to the official business at hand.
Before proceeding to the formal business, I would like to recognize the
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
